CSWM
AGIO icon

Cassady Schiller Wealth Management’s Agios Pharmaceuticals AGIO Stock Holding History

Cassady Schiller Wealth Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$493 Buy
+15
New +$705 ﹤0.01% 986

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Cassady Schiller Wealth Management's AGIO Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in Agios Pharmaceuticals (AGIO) in Q4 2024: 15 shares worth $493. The stake represents ﹤0.01% of the portfolio and ranks #986 among its holdings.

224 funds tracked by Wall St. Rank hold AGIO as of Q4 2024.

  • Cassady Schiller Wealth Management held 15 shares of Agios Pharmaceuticals worth $493 as of Q4 2024.
  • Agios Pharmaceuticals was a new Cassady Schiller Wealth Management position in Q4 2024.
  • Agios Pharmaceuticals made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #986 holding.
  • 224 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.